A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

NCT07675135 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

EDS
Cataplexy
Fatigue
Narcolepsy

Interventions

DRUG: HBS-301
OTHER: Placebo

Sponsor

Harmony Biosciences Management, Inc.